Kodiak Sciences Inc.

NASDAQ:KOD

Biotechnology

Healthcare
$97.81 -0.08%

-$0.03 today

Market cap
$6.40B
Beta
2.21
P/E (TTM)
-9.6
EPS (TTM)
-$3.73
52W Low $3.43High $47.84

Volume 0.74M

Average 1.10M

KOD Total Current Assets

All assets expected to be converted to cash or used up within one year.

Kodiak Sciences Inc.NASDAQ: KOD

Total Current Assets · Q3 FY2026 · quarter ended Sep 2026

Total current assets rises 22.7% from a year ago

Total current assets stood at $92.89M at the end of Q3 FY2026, up 22.7% from a year earlier and down 29.3% from the prior quarter. Over 3 fiscal years it compounded at -23.8% a year.

Context

  • Total current assets amounted to 44.4% of total assets at the end of Q3 FY2026, up 9.6 pp from a year earlier.
  • Total current assets increased in 1 of the last 3 fiscal years.

What to watch

Whether total current assets keeps rising in the next quarterly balance sheet after a +22.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$92.89M-29.3% QoQ
Last fiscal yearDec 2025
$214.82M+24.9% YoY
Year agoSep 2025
$75.73M+22.7% since
Total Current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+22.7%——
1 year+24.9%——
3-year CAGR-23.8%——
5-year CAGR——
10-year CAGR——

Total Current Assets history

USD · from the balance sheet

Latest · FY2025
214.82M USD
Year-over-year change
+24.9%
4-year CAGR
-26.5%

Total Current Assets vs competitors

How KOD compares with its peers on the latest reported figures

  • Peers report in different currencies, so total current assets is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +22.7% is the 3rd highest of 10, against a peer median of +17.4%.
  • Total current assets amounts to 44.4% of total assets for KOD, versus a peer median of 79.0%.
KOD Competitors
Total Current Assets for KOD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
REGNRegeneron Pharmaceuticals, Inc.Jun 2026$18.45B USD+9.4%+4.3%44.2%
BLCOBausch + Lomb CorporationJun 2026$2.92B USD+2.7%+11.7%21.1%
OCULOcular Therapeutix, Inc.Mar 2026$706M USD+82.1%+82.1%96.4%
BLTEBelite Bio, IncJun 2026$501.6M USD+232.3%+126.0%63.4%
FDMT4D Molecular Therapeutics, Inc.Mar 2026$405.36M USD+21.9%+23.3%79.0%
EYPTEyePoint Pharmaceuticals, Inc.Mar 2026$249.5M USD-23.7%+23.9%86.6%
OCSOculis Holding AGMar 2026CHF 226.36M CHF+19.9%+110.0%93.1%
KODKodiak Sciences Inc.Sep 2026$92.89M USD+22.7%-23.8%44.4%
OCGNOcugen, Inc.Mar 2026$38.55M USD-12.3%-37.2%67.7%
OTLKOutlook Therapeutics, Inc.Mar 2026$20.9M USD+17.4%-14.2%95.5%
Peer median (excluding KOD) —+17.4%+23.3%79.0%

Competitors are the stored peer set for KOD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents731.51M190.43M285.51M168.07M209.86M
Short-term Investments0288.5M000
Net Receivables00000
Inventory00000
Other Current Assets3.3M7.07M3.8M3.86M4.95M
Total Current Assets734.81M486.01M289.31M171.94M214.82M
Property, Plant & Equipment (Net)108.07M115.75M175.02M148.73M121.86M
Goodwill00000
Intangible Assets00000
Long-term Investments6.32M6.32M6.32M6.18M6.18M
Tax Assets00000
Other Non-current Assets55.01M58.55M8.72M8.73M8.67M
Total Non-current Assets169.41M180.62M190.06M163.64M136.72M
Total Assets904.22M666.63M479.37M335.58M351.53M
Account Payables12.43M9.13M13.61M3.92M12.86M
Short-term Debt3.93M9.93M9.77M012.06M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities42.13M27.41M12.27M012.84M
Total Current Liabilities64.68M52.5M41.73M25.57M45.53M
Long-term Debt99.94M100M100M0100M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities211K162K0100M1.5M
Total Non-current Liabilities176.22M177.97M171.86M159.72M148.62M
Total Liabilities240.9M230.46M213.59M185.29M194.15M
Common Stock5K5K5K5K6K
Retained Earnings(558.22M)(892.04M)(1.15B)(1.33B)(1.56B)
Accumulated OCI0(1.31M)000
Other Stockholders Equity00000
Minority Interest00000
Total Equity663.32M436.17M265.78M150.29M157.38M
Total Debt179.94M187.73M181.63M70.35M159.18M
Net Debt(551.57M)(2.7M)(103.88M)(97.73M)(50.68M)

Kodiak Sciences Inc.

NASDAQ:KOD

Intrinsic Alpha fair value

Locked

Current Price

$97.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.